- Home
- AZZ vs PTGX Comparison
AZZ vs PTGX Comparison
Compare AZZ & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AZZ | PTGX |
|---|---|---|
| Founded | 1956 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 5.4B |
| IPO Year | N/A | 2016 |
Fundamental Metrics
Financial Performance| Metric | AZZ | PTGX |
|---|---|---|
| Price | $107.37 | $94.91 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 9 |
| Target Price | ★ $116.33 | $88.33 |
| AVG Volume (30 Days) | 190.2K | ★ 902.1K |
| Earning Date | 01-07-2026 | 11-06-2025 |
| Dividend Yield | ★ 0.74% | N/A |
| EPS Growth | ★ 855.67 | N/A |
| EPS | ★ 10.37 | 0.72 |
| Revenue | ★ $1,594,766,000.00 | $209,217,000.00 |
| Revenue This Year | $5.21 | N/A |
| Revenue Next Year | $5.18 | $296.47 |
| P/E Ratio | ★ $10.38 | $132.27 |
| Revenue Growth | ★ 1.55 | N/A |
| 52 Week Low | $70.90 | $33.70 |
| 52 Week High | $119.95 | $95.26 |
Technical Indicators
Market Signals| Indicator | AZZ | PTGX |
|---|---|---|
| Relative Strength Index (RSI) | 58.83 | 70.99 |
| Support Level | $104.00 | $88.30 |
| Resistance Level | $111.49 | $92.80 |
| Average True Range (ATR) | 2.66 | 2.82 |
| MACD | 0.52 | 0.19 |
| Stochastic Oscillator | 60.08 | 94.19 |
Price Performance
Historical ComparisonAbout AZZ AZZ Inc.
AZZ Inc is a provider of galvanizing and a variety of metal coating solutions and coil coating solutions to a broad range of end markets in North America. The company's operating segment consists of Metal Coatings, Precoat Metals, and Infrastructure Solutions. The company generates the majority of its revenue from the Precoat Metals segment, which provides coil coating application of protective and decorative coatings and related value-added downstream processing for steel and aluminum coils. Geographically, the company generates the majority of its revenue from the United States.
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.